| AffyXell expands partnership with GenScript ProBio | RNS | 16.05.22 | 12:00:07 |
| London Therapeutics headquarters established | Reach | 11.05.22 | 07:00:05 |
| Block Listing Application to AIM (update) | RNS | 06.05.22 | 07:00:07 |
| Block Listing Application to AIM | RNS | 28.04.22 | 13:53:19 |
| Issue of Equity and Total Voting Rights | RNS | 14.04.22 | 17:01:03 |
| Issue of Equity and Total Voting Rights | RNS | 14.04.22 | 11:29:20 |
| AffyXell milestone and increased equity stake | RNS | 13.04.22 | 07:00:10 |
| Poster presented at the AACR available to download | RNS | 12.04.22 | 07:00:05 |
| Second Price Monitoring Extn | RNS | 11.04.22 | 16:41:24 |
| Price Monitoring Extension | RNS | 11.04.22 | 16:35:32 |
| Second Price Monitoring Extn | RNS | 11.04.22 | 14:05:44 |
| Price Monitoring Extension | RNS | 11.04.22 | 14:00:58 |
| Issue of Equity and Total Voting Rights | RNS | 08.04.22 | 13:57:24 |
| AffyXell partners with Biocytogen and KNTSC | RNS | 08.04.22 | 07:00:04 |
| Issue of Equity and Total Voting Rights | RNS | 07.04.22 | 16:31:15 |
| Preliminary Results | RNS | 06.04.22 | 07:00:07 |
| Second Price Monitoring Extn | RNS | 30.03.22 | 16:41:09 |
| Price Monitoring Extension | RNS | 30.03.22 | 16:35:49 |
| Notice of Results and Investor Presentation | RNS | 30.03.22 | 07:00:06 |
| AVA6000 data poster presentation at AACR | RNS | 29.03.22 | 07:00:09 |
